Where does AbbVie Biotechnology Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AbbVie Biotechnology Ltd. ranks #5,420 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AbbVie Biotechnology Ltd. hold?

AbbVie Biotechnology Ltd. holds 63 US utility patents granted between 2015 and 2023, spanning 11 technology areas.

What is AbbVie Biotechnology Ltd.'s Innovation Score?

AbbVie Biotechnology Ltd. has an Innovation Score of 41.9 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AbbVie Biotechnology Ltd. focus on?

AbbVie Biotechnology Ltd.'s top technology area is C07K (Peptides) with 48 patents, ranking #190 of 3,615 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is AbbVie Biotechnology Ltd.'s patent grant rate increasing or decreasing?

AbbVie Biotechnology Ltd.'s recent grant velocity is -93% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for AbbVie Biotechnology Ltd.'s patents?

AbbVie Biotechnology Ltd.'s patents average 22.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AbbVie Biotechnology Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AbbVie Biotechnology Ltd.

USPTO PatentsView assignee record - 63 granted patents across 11 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbvie ranks #5,420 of 49,997 tracked US assignees by granted-patent volume, with 63 patents across 11 technology areas.

#5,420
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 22.6
avg claims per patent: -93%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5420 · Foreign Corporation #5,420 · 63 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 63 grants
UPPER-Q #5,420/49,997
PHOTO-FINISH Advanced Drainage…
CPC-FOCUS C07K · 11 areas
INNOV-PAR 41.9/100
CLAIMS-DENSE 22.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -93% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Advanced Drainage Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abbvie’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.4 pts (34%) Velocity 2.2 pts (5%) Breadth 11.7 pts (28%) Claim depth 13.5 pts (32%)

Qualcomm Incorporated · highest

85
AbbVie Biotechnology · this assignee

42
Gaumard Scientific · near

42
Guest Tek Interactiv… · near

42
Sanford-Burnham… · near

42
Ubright Optronics · near

42
3D Lighting… · lowest

7

What this shows Abbvie's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abbvie?

Each dot is one of Abbvie’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbvie’s own 22.6 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abbvie vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abbvie's grants concentrate

AbbVie Biotechnology Ltd. is a focused PatentsView assignee: 11 CPC subclasses with 76.2% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (25 grants) versus a trough of 1 in 2023. By volume, Abbvie sits between iLumisys, Inc. and Ansell Limited.

Abbvie's three-year grant acceleration

AbbVie Biotechnology Ltd. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

ilumisys

64
Asapp

63
Asia Optical Inte…

63
Atlantic Inertial…

63
Advanced Drainage…

63
Affectiva

63
Agfa-gevaert

63
Ansell

63
Abbvie Biotechnol… ◀

63

What this shows AbbVie holds 63 patents at rank #5,423, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AbbVie

By rank, the assignees closest to #5,423 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in AbbVie's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AbbVie, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), AbbVie ranks #190 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Gaumard Scientific Company, Inc. 42 Sanford-Burnham Medical Research Institute 42 Guest Tek Interactive Entertainment Ltd. 42 Ubright Optronics Corporation 42

Similar claim depth

Nearest assignees by average claims per patent (22.6 here).

Grail, Inc. 22.6 avg Magnolia Medical Technologies, Inc. 22.6 avg Seminis Vegetable Seeds, Inc. 22.6 avg Blue River Technology Inc. 22.6 avg

Abbvie's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

AbbVie Biotechnology Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	25	39.7%
2016	19	30.2%
2017	11	17.5%
2018	4	6.3%
2021	3	4.8%
2023	1	1.6%

Which technologies does AbbVie Biotechnology Ltd. patent most?

C07K - Peptides 48

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 48

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 45

Y02A - Technologies FOR Adaptation TO Climate Change 33

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

Y10T - Technical Subjects Covered BY Former US Classification 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61B - DIAGNOSIS; SURGERY; Identification 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 2

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AbbVie Biotechnology Ltd.'s patent record in context - here's where to go next.

AbbVie Biotechnology Ltd.'s lead technology class is C07K (Peptides), 76.2% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #5,420 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AbbVie Biotechnology Ltd. against iLumisys, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.